Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RBM6 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | PCDHAC1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | OTOG | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ATOX1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
mRNA | SYT17 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ATP8A2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | TEF | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | PNISR | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ADAMTS6 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | DCHS2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |